The GLP-1 receptor agonist Exenatide reduces serum TSH by its effect on body weight in people with Type 2 Diabetes

Lookup NU author(s): Dr Salman Razvi

The full text of this item is currently under embargo and cannot be made publicly available until 26/02/2024.

Author(s): Tee SuAnn, Tsatlidis V, Razvi S

Publication type: Article

Publication status: Published

Journal: Clinical Endocrinology

Year: 2023

Pages: Epub ahead of print

Online publication date: 26/02/2023

Acceptance date: 24/02/2023

Date deposited: 24/02/2023

ISSN (print): 0300-0664

ISSN (electronic): 1365-2265

Publisher: Wiley-Blackwell Publishing Ltd.

URL: https://doi.org/10.1111/cen.14901

DOI: 10.1111/cen.14901

ePrints DOI: 10.57711/x8nr-h689

Altmetrics provided by Altmetric

ePrints